National Microbiology Laboratory, 1015 Arlington Street, Winnipeg, Manitoba, Canada.
J Virol. 2012 Jan;86(2):1166-80. doi: 10.1128/JVI.05721-11. Epub 2011 Nov 9.
A subset of women in the Pumwani Sex Worker Cohort, established in 1985 in Nairobi, Kenya, remains uninfected despite repeated high-risk exposure (HIV-exposed, seronegative [HESN]) through active sex work. This HESN phenotype is associated with several alleles of human leukocyte antigens (HLAs) and specific CD8(+) and CD4(+) T cell responses to HIV-1. The associations of HLA alleles with differential HIV-1 infection are most likely due to their different abilities to present antigen and the different immune responses they induce. The characteristics of epitopes of HLA alleles associated with different outcomes of HIV-1 infection might therefore point to a vital clue for developing an effective vaccine. In this study, we systematically analyzed HIV-1 clade A and D Gag CD8(+) T cell epitopes of two HLA class I alleles associated with different outcomes of HIV-1 infection. Binding affinity and off-rates of the identified epitopes were determined. Gamma interferon (IFN-γ) enzyme-linked immunospot (ELISpot) assays with patient peripheral blood mononuclear cells (PBMCs) validated the epitopes. Epitope-specific CD8(+) T cells were further phenotyped for memory markers with tetramer staining. Our study showed that the protective allele A01:01 recognizes only three Gag epitopes. By contrast, B07:02, the allele associated with susceptibility, binds 30 epitope variants. These two alleles differ most importantly in the spectrum of Gag epitopes they can present and not in affinity, off-rates, the location of the epitopes, or epitope-specific Tem/Tcm frequencies. The binding of more epitopes and strong IFN-gamma ELISpot responses are associated with susceptibility to HIV-1 infection, while more focused antigen recognition of multiple subtypes is protective. Rational vaccine design should take these observations into account.
在肯尼亚内罗毕于 1985 年建立的 pumwani 性工作者队列中,一部分女性尽管通过积极的性工作反复接触高危因素(HIV 暴露但血清阴性[HESN]),但仍然没有感染。这种 HESN 表型与人类白细胞抗原(HLA)的几个等位基因以及针对 HIV-1 的特定 CD8(+)和 CD4(+)T 细胞反应有关。HLA 等位基因与 HIV-1 感染的差异相关,最有可能是因为它们具有不同的呈递抗原能力和诱导的不同免疫反应。因此,与 HIV-1 感染不同结果相关的 HLA 等位基因的表位特征可能指向开发有效疫苗的重要线索。在这项研究中,我们系统地分析了与 HIV-1 感染不同结果相关的两个 HLA Ⅰ类等位基因的 HIV-1 群 A 和 D gag CD8(+)T 细胞表位。确定了结合亲和力和脱离率。用患者外周血单核细胞(PBMC)进行γ干扰素(IFN-γ)酶联免疫斑点(ELISpot)分析验证了这些表位。通过四聚体染色进一步对表位特异性 CD8(+)T 细胞进行记忆标志物表型分析。我们的研究表明,保护性等位基因 A01:01 仅识别三个 gag 表位。相比之下,与易感性相关的等位基因 B07:02 结合 30 个表位变体。这两个等位基因最重要的区别在于它们可以呈递的 gag 表位谱,而不是亲和力、脱离率、表位位置或表位特异性 Tem/Tcm 频率。更多表位的结合和强烈的 IFN-γ ELISpot 反应与 HIV-1 感染的易感性相关,而对多种亚型的更集中的抗原识别则具有保护作用。合理的疫苗设计应考虑到这些观察结果。